High-Purity DOTA (CAS 60239-18-1): Your Premier Supplier for Advanced MRI Agents and Radiopharmaceuticals
As a leading manufacturer and supplier of high-quality pharmaceutical intermediates, NINGBO INNO PHARMCHEM CO.,LTD. offers DOTA (CAS 60239-18-1), a critical chelating agent vital for advanced medical imaging and therapeutic applications. Discover the exceptional purity and reliability of our DOTA, sourced and produced to meet the stringent demands of the pharmaceutical industry. Partner with us for your critical raw material needs and ensure the efficacy and safety of your final products.
Get a Quote & SampleUnlocking Advanced Medical Imaging with DOTA
DOTA: The Gold Standard Chelator
NINGBO INNO PHARMCHEM CO.,LTD. is your trusted supplier of DOTA (CAS 60239-18-1), a macrocyclic chelating agent renowned for its exceptional stability and versatility. Our DOTA, with a purity of 98%min and appearing as a white solid, is a cornerstone for developing advanced MRI contrast agents and innovative radiopharmaceuticals. We ensure a stable supply chain and competitive pricing for our esteemed partners globally.
- Exceptional Purity: Procure high-purity DOTA, a crucial pharmaceutical intermediate with a minimum purity of 98%, ensuring reliable performance in sensitive medical applications.
- Versatile Applications: Explore the widespread use of DOTA as a key component in MRI contrast agents, diagnostic tools, and therapeutic radiopharmaceuticals, vital for cancer treatment and diagnosis.
- Stable Supply from China: As a dedicated manufacturer, we guarantee a consistent and stable supply of DOTA, supporting your production schedules and market demands.
- Cost-Effective Solutions: We offer competitive pricing for DOTA, making it an accessible and economically viable choice for your research and manufacturing needs.
Why Choose NINGBO INNO PHARMCHEM for DOTA?
Unmatched Stability and Affinity
DOTA's unique structure provides superior thermodynamic stability and kinetic inertness when complexed with metal ions, especially lanthanides like Gadolinium (Gd3+). This makes it the preferred chelator for MRI contrast agents, ensuring patient safety and diagnostic accuracy. Trust NINGBO INNO PHARMCHEM for DOTA that meets these exacting standards.
Enabling Next-Generation Radiopharmaceuticals
The ability of DOTA to chelate radioisotopes like Yttrium-90 (90Y) and Lutetium-177 (177Lu) makes it indispensable for targeted radiotherapies. By conjugating DOTA to targeting vectors, we facilitate the precise delivery of radiation to cancer cells. Buy DOTA from us to advance your radiopharmaceutical development programs.
Reliable Pharmaceutical Intermediate Supplier
As a prominent manufacturer in China, NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing reliable access to essential pharmaceutical intermediates like DOTA. Our rigorous quality control ensures that every batch meets the highest industry standards, supporting your journey from R&D to commercial production. Secure your supply of DOTA with a dependable partner.
Key Applications of DOTA
MRI Contrast Agents
DOTA's high affinity for Gadolinium (Gd3+) makes it a critical component in MRI contrast agents, enhancing diagnostic clarity for neurological, vascular, and other medical imaging procedures. Purchase DOTA for your MRI agent formulations.
Radiopharmaceuticals for Cancer Therapy
Used to chelate therapeutic radioisotopes, DOTA is crucial for developing targeted alpha and beta therapy agents. Its stability ensures efficient delivery of radiation to tumors. Explore DOTA as a pharmaceutical intermediate for your cancer treatment solutions.
Diagnostic Imaging
DOTA chelates radioisotopes for PET and SPECT imaging, aiding in the detection and staging of various diseases, including neuroendocrine tumors. Ensure consistent quality by choosing NINGBO INNO PHARMCHEM as your DOTA supplier.
Bioconjugation and Targeted Drug Delivery
The functional groups on DOTA allow for conjugation to antibodies or peptides, enabling targeted delivery of imaging or therapeutic agents to specific cells or tissues. We are a preferred supplier for DOTA in complex bioconjugation strategies.